Edesa anticipates topline results could be available within as few as 12 to 18 months following regulatory clearance by the FDA. Health Canada has previously granted approval to initiate this Phase 2 ...

Varshavski: I asked a bunch of different specialists what's the one medical breakthrough they're excited about in their ...

A local establishment was awarded more than $70,000 in grants in connection to some innovation development projects.

ELMSFORD, N.Y. - NanoVibronix , Inc. (NASDAQ:NAOV), a medical device company with a current market capitalization of $2.25 million, has announced the acquisition of ENvue Medical (TASE:PMCN) Holdings ...

Start-up accelerators are designed to rapidly scale early-stage companies through mentorship, funding and resources.

Nano-X Imaging is a disruptive biotech investment. The AI push in the health sector is a long-term tailwind. See why we rate ...

What are "indirect costs" for universities? Why are some young scientists looking at opportunities abroad? And why are AI ...

Virginia Tech is leading the effort that aims to strengthen bonds between biomedical companies and sector leaders.

Backed by Goldman Sachs, Novo Nordisk’s parent company and others, Newleos Therapeutics debuted Thursday with $94 million and ...

Isomorphic Labs, a spin-off from DeepMind, is applying AI-first principles to drug discovery rather than just protein ...

BRAIN Biotech is contributing its proprietary bioleaching technology as the core technology for recovering of BioGold TM. The PX Urban Mining Initiative is open to additional partners who wish to ...

The expanded collaboration between BRAIN Biotech and PX Group is a key part of the PX Urban Mining Initiative, an industry and academic network focused on developing and implementing disruptive, ...